Robert D. Allen Iii Adagio Therapeutics, Inc. (ADGI) insider trading activity

ADGI Quotes by TradingView

Robert D. Allen Iii is Chief Scientific Officer of Adagio Therapeutics, Inc.. Currently has a direct ownership of 53,068 shares of ADGI, which is worth approximately $175,655. The most recent transaction as insider was on Aug 19, 2025, when has been sold 27,420 shares (Common Stock) at a price of $0.57 per share, resulting in proceeds of $15,629. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 53.1K
n/a 3M change
n/a 12M change
Total Value Held $175,655

Robert D. Allen III Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 19 2025
SELL
Open market or private sale
$15,629 $0.57 p/Share
27,420 Reduced 34.07%
53,068 Common Stock
Aug 18 2025
SELL
Open market or private sale
$12,032 $0.65 p/Share
18,512 Reduced 18.7%
80,488 Common Stock
Aug 15 2025
BUY
Exercise of conversion of derivative security
-
99,000 Added 50.0%
99,000 Common Stock
RDA

Robert D. Allen Iii

Chief Scientific Officer
Waltham, MA

Track Institutional and Insider Activities on ADGI

Follow Adagio Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADGI shares.

Notify only if

Insider Trading

Get notified when an Adagio Therapeutics, Inc. insider buys or sells ADGI shares.

Notify only if

News

Receive news related to Adagio Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ADGI